Intervention
vinorelbine tartrate
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 40 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
40 shownVeliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerNCT01104259 · 2010-07-01
COMPLETEDFirst-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung CancerNCT01097317 · 2009-09-01
UNKNOWNChemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerNCT00863512 · 2009-03-01
TERMINATEDFirst-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT00736814 · 2008-06-01
UNKNOWNMitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyNCT00627354 · 2006-09-01
COMPLETEDVinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00309998 · 2005-09-01
COMPLETEDHormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerNCT00194792 · 2005-08-01
TERMINATEDRadiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNCT00253591 · 2005-06-01
COMPLETEDFludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung CancerNCT00083083 · 2005-03-01
UNKNOWNVinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerNCT00103233 · 2004-12-01
COMPLETEDCapecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast CancerNCT00093808 · 2004-08-01
COMPLETEDTopotecan and Vinorelbine in Treating Patients With Recurrent Lung CancerNCT00287963 · 2004-02-01
COMPLETEDCombination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryNCT00194779 · 2003-10-01
COMPLETEDActive Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural MesotheliomaNCT00075699 · 2003-09-01
COMPLETEDPolyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerNCT00054197 · 2003-01-01
TERMINATEDCapecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerNCT00049660 · 2002-09-01
TERMINATEDVinorelbine in Treating Older Women With Stage IV Breast CancerNCT00022152 · 2001-11-01
COMPLETEDS0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerNCT00026156 · 2001-11-01
COMPLETEDVinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00008333 · 2001-04-01
COMPLETEDBevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast CancerNCT00017394 · 2001-03-01
COMPLETEDVinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerNCT00079287 · 2001-03-01
COMPLETEDPalliative Therapy With or Without Chemotherapy in Treating Patients With Malignant MesotheliomaNCT00030459 · 2000-11-01
UNKNOWNCisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00017459 · 2000-07-01
COMPLETEDVinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00005865 · 2000-04-01
COMPLETEDCombination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryNCT00005838 · 2000-03-01
COMPLETEDDocetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00006215 · 1999-10-01
UNKNOWNCombination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNCT00006114 · 1999-05-01
UNKNOWNCapecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone InvolvementNCT00003902 · 1999-03-01
COMPLETEDVinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone TherapyNCT00003622 · 1999-01-01
WITHDRAWNVinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast CancerNCT00003730 · 1998-12-01
COMPLETEDChemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00004100 · 1998-11-01
UNKNOWNComparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast CancerNCT00004237 · 1998-10-01
COMPLETEDCombination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00005825 · 1998-09-01
UNKNOWNCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate CancerNCT00003400 · 1998-09-01
COMPLETEDVinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00003447 · 1998-07-01
UNKNOWNVinorelbine in Treating Patients With Metastatic Prostate CancerNCT00003259 · 1997-10-01
COMPLETEDSurgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung CancerNCT00003159 · 1997-08-01
COMPLETEDStandard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerNCT00003240 · 1995-10-01
UNKNOWNHydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung CancerNCT00002887 · 1995-07-01
UNKNOWNCombination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung CancerNCT00002823 · 1995-02-01
COMPLETEDCommon conditions
Lung Cancer21Breast Cancer7Prostate Cancer5Estrogen Receptor-negative Breast Cancer2Estrogen Receptor-positive Breast Cancer2HER2-negative Breast Cancer2Male Breast Cancer2Malignant Mesothelioma2Progesterone Receptor-negative Breast Cancer2Progesterone Receptor-positive Breast Cancer2Recurrent Breast Cancer2Stage II Breast Cancer2Stage IIIA Breast Cancer2Stage IV Breast Cancer2Adenocarcinoma of the Lung1Adenosquamous Cell Lung Cancer1Chemotherapeutic Agent Toxicity1Fatigue1HER2-positive Breast Cancer1Hereditary Breast/Ovarian Cancer - BRCA11Hereditary Breast/Ovarian Cancer - BRCA21Large Cell Lung Cancer1Musculoskeletal Complications1Squamous Cell Lung Cancer1Stage I Breast Cancer1
Leading sponsors
Alliance for Clinical Trials in Oncology
4
Medical Research Council
3
National Cancer Institute (NCI)
3
University of Washington
3
European Organisation for Research and Treatment of Cancer - EORTC
2
Istituto Nazionale per lo Studio e la Cura dei Tumori
2
Swiss Cancer Institute
2
SWOG Cancer Research Network
2
American College of Radiology Imaging Network
1
Amgen
1
British Thoracic Society
1
CTI BioPharma
1
GERCOR - Multidisciplinary Oncology Cooperative Group
1
GlaxoSmithKline
1
Groupe D'Etude des Tumeurs Uro-Genitales
1
Trial status mix
COMPLETED24
UNKNOWN11
TERMINATED4
WITHDRAWN1
Phase mix
PHASE224
PHASE314
PHASE14
NA1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.